Nestin: A novel angiogenesis marker and possible target for tumor angiogenesis

World Journal of Gastroenterology

Volumn 19, Issue 1, 2013, Pages 42-48

  Matsuda, Yoko ^a   Hagio, Masahito ^a   Ishiwata, Toshiyuki ^a  

^a NIPPON MEDICAL SCHOOL   (Japan)

Author keywords

Angiogenesis; CD31; CD34; Factor VIII; Gastrointestinal cancer; Microvessel density; Molecular targeting therapy; Nestin; Pancreatic cancer

Indexed keywords

BEVACIZUMAB; BIOLOGICAL MARKER; BLOOD CLOTTING FACTOR 8; CD31 ANTIGEN; CD34 ANTIGEN; GEMCITABINE; NESTIN; VASCULOTROPIN;

ANGIOGENESIS; CANCER GROWTH; CANCER INHIBITION; CANCER SURVIVAL; CELL DIFFERENTIATION; CELL PROLIFERATION; ENDOTHELIAL PROGENITOR CELL; GENE SILENCING; HUMAN; IMMUNOHISTOCHEMISTRY; MICROVASCULATURE; NEOVASCULARIZATION (PATHOLOGY); PANCREAS CANCER; PHASE 2 CLINICAL TRIAL (TOPIC); PHASE 3 CLINICAL TRIAL (TOPIC); PROTEIN EXPRESSION; REVIEW; SIGNAL TRANSDUCTION; VASCULAR ENDOTHELIUM;

EID: 84873622320     PISSN: 10079327     EISSN: 22192840     Source Type: Journal    
DOI: 10.3748/wjg.v19.i1.42     Document Type: Review

References (86)

1. Liotta LA, Saidel MG, Kleinerman J. The significance of hematogenous tumor cell clumps in the metastatic process. Cancer Res 1976; 36: 889-894 [PMID: 1253177]
2. Folkman J. What is the evidence that tumors are angiogenesis dependent? J Natl Cancer Inst 1990; 82: 4-6 [PMID: 1688381]
3. Papamichael D. Prognostic role of angiogenesis in colorectal cancer. Anticancer Res 2001; 21: 4349-4353 [PMID: 11908690]
4. Saito H, Tsujitani S. Angiogenesis, angiogenic factor expression and prognosis of gastric carcinoma. Anticancer Res 2001; 21: 4365-4372 [PMID: 11908692]
5. Nakagawa S, Nishimaki T, Suzuki T, Kanda T, Kuwabara S, Hatakeyama K. Tumor angiogenesis as an independent prognostic factor after extended radical esophagectomy for invasive squamous cell carcinoma of the esophagus. Surgery 2001; 129: 302-308 [PMID: 11231458 DOI: 10.1067/msy.2001.111122]
6. Ikeda N, Adachi M, Taki T, Huang C, Hashida H, Takabayashi A, Sho M, Nakajima Y, Kanehiro H, Hisanaga M, Nakano H, Miyake M. Prognostic significance of angiogenesis in human pancreatic cancer. Br J Cancer 1999; 79: 1553-1563 [PMID: 10188906 DOI: 10.1038/sj.bjc.6690248]
7. Kuwahara K, Sasaki T, Kuwada Y, Murakami M, Yamasaki S, Chayama K. Expressions of angiogenic factors in pancreatic ductal carcinoma: a correlative study with clinicopathologic parameters and patient survival. Pancreas 2003; 26: 344-349 [PMID: 12717266]
8. Macchiarini P, Fontanini G, Hardin MJ, Squartini F, Angeletti CA. Relation of neovascularisation to metastasis of non-small-cell lung cancer. Lancet 1992; 340: 145-146 [PMID: 1378165 DOI: 0140-6736(92)93217-B]
9. Hansen S, Grabau DA, Rose C, Bak M, Sørensen FB. Angiogenesis in breast cancer: a comparative study of the observer variability of methods for determining microvessel density. Lab Invest 1998; 78: 1563-1573 [PMID: 9881956]
10. Schoell WM, Pieber D, Reich O, Lahousen M, Janicek M, Guecer F, Winter R. Tumor angiogenesis as a prognostic factor in ovarian carcinoma: quantification of endothelial immunoreactivity by image analysis. Cancer 1997; 80: 2257-2262 [PMID: 9404702 DOI: 10.1002/(SICI)1097-0142(19971215)80]
11. Tanigawa N, Matsumura M, Amaya H, Kitaoka A, Shimomatsuya T, Lu C, Muraoka R, Tanaka T. Tumor vascularity correlates with the prognosis of patients with esophageal squamous cell carcinoma. Cancer 1997; 79: 220-225 [PMID: 9010094 DOI: 10.1002/(SICI)1097-0142(19970115)79]
12. Tanigawa N, Amaya H, Matsumura M, Shimomatsuya T. Association of tumour vasculature with tumour progression and overall survival of patients with non-early gastric carcinomas. Br J Cancer 1997; 75: 566-571 [PMID: 9052412]
13. Takahashi Y, Tucker SL, Kitadai Y, Koura AN, Bucana CD, Cleary KR, Ellis LM. Vessel counts and expression of vascular endothelial growth factor as prognostic factors in nodenegative colon cancer. Arch Surg 1997; 132: 541-546 [PMID: 9161399]
14. Wakui S, Furusato M, Itoh T, Sasaki H, Akiyama A, Kinoshita I, Asano K, Tokuda T, Aizawa S, Ushigome S. Tumour angiogenesis in prostatic carcinoma with and without bone marrow metastasis: a morphometric study. J Pathol 1992; 168: 257-262 [PMID: 1281874 DOI: 10.1002/path.1711680303]
15. Takagi K, Takada T, Amano H, Yoshida M, Miura H, Toyota N, Wada K, Takahashi I. Analysis of microvessels in pancreatic cancer: by light microscopy, confocal laser scan microscopy, and electron microscopy. J Hepatobiliary Pancreat Surg 2008; 15: 384-390 [PMID: 18670839 DOI: 10.1007/s00534-007-1241-6]
16. Takagi K, Takada T, Amano H. A high peripheral microvessel density count correlates with a poor prognosis in pancreatic cancer. J Gastroenterol 2005; 40: 402-408 [PMID: 15870976 DOI: 10.1007/s00535-004-1556-x]
17. Meert AP, Paesmans M, Martin B, Delmotte P, Berghmans T, Verdebout JM, Lafitte JJ, Mascaux C, Sculier JP. The role of microvessel density on the survival of patients with lung cancer: a systematic review of the literature with meta-analysis. Br J Cancer 2002; 87: 694-701 [PMID: 12232748 DOI: 10.1038/sj.bjc.6600551]
18. Lendahl U, Zimmerman LB, McKay RD. CNS stem cells express a new class of intermediate filament protein. Cell 1990; 60: 585-595 [PMID: 1689217 DOI: 0092-8674(90)90662-X]
19. Steinert PM, Chou YH, Prahlad V, Parry DA, Marekov LN, Wu KC, Jang SI, Goldman RD. A high molecular weight intermediate filament-associated protein in BHK-21 cells is nestin, a type VI intermediate filament protein. Limited co-assembly in vitro to form heteropolymers with type III vimentin and type IV alpha-internexin. J Biol Chem 1999; 274: 9881-9890 [PMID: 10092680]
20. Marvin MJ, Dahlstrand J, Lendahl U, McKay RD. A rod end deletion in the intermediate filament protein nestin alters its subcellular localization in neuroepithelial cells of transgenic mice. J Cell Sci 1998; 111 (Pt 14): 1951-1961 [PMID: 9645943]
21. Sjöberg G, Edström L, Lendahl U, Sejersen T. Myofibers from Duchenne/Becker muscular dystrophy and myositis express the intermediate filament nestin. J Neuropathol Exp Neurol 1994; 53: 416-423 [PMID: 8021716]
22. Sahlgren CM, Mikhailov A, Vaittinen S, Pallari HM, Kalimo H, Pant HC, Eriksson JE. Cdk5 regulates the organization of Nestin and its association with p35. Mol Cell Biol 2003; 23: 5090-5106 [PMID: 12832492]
23. Sahlgren CM, Mikhailov A, Hellman J, Chou YH, Lendahl U, Goldman RD, Eriksson JE. Mitotic reorganization of the intermediate filament protein nestin involves phosphorylation by cdc2 kinase. J Biol Chem 2001; 276: 16456-16463 [PMID: 11278541 DOI: 10.1074/jbc.M009669200]
24. Suzuki S, Namiki J, Shibata S, Mastuzaki Y, Okano H. The neural stem/progenitor cell marker nestin is expressed in proliferative endothelial cells, but not in mature vasculature. J Histochem Cytochem 2010; 58: 721-730 [PMID: 20421592 DOI: 10.1369/jhc.2010.955609]
25. Ishiwata T, Matsuda Y, Naito Z. Nestin in gastrointestinal and other cancers: effects on cells and tumor angiogenesis. World J Gastroenterol 2011; 17: 409-418 [PMID: 21274370 DOI: 10.3748/wjg.v17.i4.409]
26. Gravdal K, Halvorsen OJ, Haukaas SA, Akslen LA. Proliferation of immature tumor vessels is a novel marker of clinical progression in prostate cancer. Cancer Res 2009; 69: 4708-4715 [PMID: 19487287 DOI: 10.1158/0008-5472.CAN-08-4417]
27. Yamahatsu K, Matsuda Y, Ishiwata T, Uchida E, Naito Z. Nestin as a novel therapeutic target for pancreatic cancer via tumor angiogenesis. Int J Oncol 2012; 40: 1345-1357 [PMID: 22246533 DOI: 10.3892/ijo.2012.1333]
28. Mokrý J, Nemecek S. Angiogenesis of extra- and intraembryonic blood vessels is associated with expression of nestin in endothelial cells. Folia Biol (Praha) 1998; 44: 155-161 [PMID: 10732706]
29. Mokrý J, Nemecek S. Cerebral angiogenesis shows nestin expression in endothelial cells. Gen Physiol Biophys 1999; 18 Suppl 1: 25-29 [PMID: 10707828]
30. Mokrý J, Cízková D, Filip S, Ehrmann J, Osterreicher J, Kolár Z, English D. Nestin expression by newly formed human blood vessels. Stem Cells Dev 2004; 13: 658-664 [PMID: 15684833 DOI: 10.1089/scd.2004.13.658]
31. Hanahan D, Folkman J. Patterns and emerging mechanisms of the angiogenic switch during tumorigenesis. Cell 1996; 86: 353-364 [PMID: 8756718 DOI: S0092-8674(00)80108-7]
32. Ishiwata T, Kudo M, Onda M, Fujii T, Teduka K, Suzuki T, Korc M, Naito Z. Defined localization of nestin-expressing cells in L-arginine-induced acute pancreatitis. Pancreas 2006; 32: 360-368 [PMID: 16670618 DOI: 10.1097/01.mpa. 0000220860.01120.21]
33. Aki R, Amoh Y, Li L, Katsuoka K, Hoffman RM. Nestinexpressing interfollicular blood vessel network contributes to skin transplant survival and wound healing. J Cell Biochem 2010; 110: 80-86 [PMID: 20225276 DOI: 10.1002/jcb.22512]
34. El-Helou V, Beguin PC, Assimakopoulos J, Clement R, Gosselin H, Brugada R, Aumont A, Biernaskie J, Villeneuve L, Leung TK, Fernandes KJ, Calderone A. The rat heart contains a neural stem cell population; role in sympathetic sprouting and angiogenesis. J Mol Cell Cardiol 2008; 45: 694-702 [PMID: 18718475 DOI: 10.1016/j.yjmcc.2008.07.013]
35. Calderone A. Nestin+ cells and healing the infarcted heart. Am J Physiol Heart Circ Physiol 2012; 302: H1-H9 [PMID: 22003051 DOI: 10.1152/ajpheart.00716.2011]
36. Takahashi N, Itoh MT, Ishizuka B. Human chorionic gonadotropin induces nestin expression in endothelial cells of the ovary via vascular endothelial growth factor signaling. Endocrinology 2008; 149: 253-260 [PMID: 17916630 DOI: 10.1210/en.2007-0774]
37. Abdul Rahman H, Manzor NF, Tan GC, Tan AE, Chua KH. Upregulation of SOX-2, FZD9, Nestin, OCT-4 and FGF-4 expression in human chorion derived-stem cells after angiogenic induction. Med J Malaysia 2008; 63 Suppl A: 57-58 [PMID: 19024982]
38. Kim BK, Kim SE, Shim JH, Woo DH, Gil JE, Kim SK, Kim JH. Neurogenic effect of vascular endothelial growth factor during germ layer formation of human embryonic stem cells. FEBS Lett 2006; 580: 5869-5874 [PMID: 17027979 DOI: 10.1016/j.febslet.2006.09.053]
39. Raab S, Beck H, Gaumann A, Yüce A, Gerber HP, Plate K, Hammes HP, Ferrara N, Breier G. Impaired brain angiogenesis and neuronal apoptosis induced by conditional homozygous inactivation of vascular endothelial growth factor. Thromb Haemost 2004; 91: 595-605 [PMID: 14983237 DOI: 10.1160/TH03-09-058]
40. Plaschke K, Staub J, Ernst E, Marti HH. VEGF overexpression improves mice cognitive abilities after unilateral common carotid artery occlusion. Exp Neurol 2008; 214: 285-292 [PMID: 18822285 DOI: 10.1016/j.expneurol.2008.08.014]
41. Hwang HS, Cho NH, Maeng YS, Kang MH, Park YW, Kim YH. Differential expression of nestin in normal and pre-eclamptic human placentas. Acta Obstet Gynecol Scand 2007; 86: 909-914 [PMID: 17653873 DOI: 10.1080/00016340701417018]
42. Teranishi N, Naito Z, Ishiwata T, Tanaka N, Furukawa K, Seya T, Shinji S, Tajiri T. Identification of neovasculature using nestin in colorectal cancer. Int J Oncol 2007; 30: 593-603 [PMID: 17273760]
43. Salehi F, Kovacs K, Cusimano MD, Horvath E, Bell CD, Rotondo F, Scheithauer BW. Immunohistochemical expression of nestin in adenohypophysial vessels during development of pituitary infarction. J Neurosurg 2008; 108: 118-123 [PMID: 18173320 DOI: 10.3171/JNS/2008/108/01/0118]
44. Kim HS, Kang HS, Messam CA, Min KW, Park CS. Comparative evaluation of angiogenesis in gastric adenocarcinoma by nestin and CD34. Appl Immunohistochem Mol Morphol 2002; 10: 121-127 [PMID: 12051629]
45. Hlobilkova A, Ehrmann J, Knizetova P, Krejci V, Kalita O, Kolar Z. Analysis of VEGF, Flt-1, Flk-1, nestin and MMP-9 in relation to astrocytoma pathogenesis and progression. Neoplasma 2009; 56: 284-290 [PMID: 19473053]
46. Brychtova S, Fiuraskova M, Hlobilková A, Brychta T, Hinak J. Nestin expression in cutaneous melanomas and melanocytic nevi. J Cutan Pathol 2007; 34: 370-375 [PMID: 17448190 DOI: 10.1111/j.1600-0560.2006.00627.x]
47. Schiffer D, Annovazzi L, Caldera V, Mellai M. On the origin and growth of gliomas. Anticancer Res 2010; 30: 1977-1998 [PMID: 20651342]
48. Dong J, Zhao Y, Huang Q, Fei X, Diao Y, Shen Y, Xiao H, Zhang T, Lan Q, Gu X. Glioma stem/progenitor cells contribute to neovascularization via transdifferentiation. Stem Cell Rev 2011; 7: 141-152 [PMID: 20697979 DOI: 10.1007/s12015-010-9169-7]
49. Amoh Y, Li L, Yang M, Moossa AR, Katsuoka K, Penman S, Hoffman RM. Nascent blood vessels in the skin arise from nestin-expressing hair-follicle cells. Proc Natl Acad Sci USA 2004; 101: 13291-13295 [PMID: 15331785 DOI: 10.1073/pnas.0405250101]
50. Hoffman RM. Nestin-driven green fluorescent protein as an imaging marker for nascent blood vessels in mouse models of cancer. Methods Mol Biol 2011; 689: 183-204 [PMID: 21153793 DOI: 10.1007/978-1-60761-950-5_11]
51. Amoh Y, Yang M, Li L, Reynoso J, Bouvet M, Moossa AR, Katsuoka K, Hoffman RM. Nestin-linked green fluorescent protein transgenic nude mouse for imaging human tumor angiogenesis. Cancer Res 2005; 65: 5352-5357 [PMID: 15958583 DOI: 10.1158/0008-5472.CAN-05-0821]
52. Amoh Y, Bouvet M, Li L, Tsuji K, Moossa AR, Katsuoka K, Hoffman RM. Visualization of nascent tumor angiogenesis in lung and liver metastasis by differential dual-color fluorescence imaging in nestin-linked-GFP mice. Clin Exp Metastasis 2006; 23: 315-322 [PMID: 17136576 DOI: 10.1007/s10585-006-9018-x]
53. Jemal A, Siegel R, Ward E, Hao Y, Xu J, Murray T, Thun MJ. Cancer statistics, 2008. CA Cancer J Clin 2008; 58: 71-96 [PMID: 18287387 DOI: 10.3322/CA.2007.0010]
54. Warshaw AL, Fernández-del Castillo C. Pancreatic carcinoma. N Engl J Med 1992; 326: 455-465 [PMID: 1732772 DOI: 10.1056/NEJM199202133260706]
55. Assifi MM, Hines OJ. Anti-angiogenic agents in pancreatic cancer: a review. Anticancer Agents Med Chem 2011; 11: 464-469 [PMID: 21521158 DOI: 10.2174/18715201179567746]
56. Matsuda Y, Naito Z, Kawahara K, Nakazawa N, Korc M, Ishiwata T. Nestin is a novel target for suppressing pancreatic cancer cell migration, invasion and metastasis. Cancer Biol Ther 2011; 11: 512-523 [PMID: 21258211 DOI: 10.4161/cbt.11.5.14673]
57. Newman PJ, Berndt MC, Gorski J, White GC, Lyman S, Paddock C, Muller WA. PECAM-1 (CD31) cloning and relation to adhesion molecules of the immunoglobulin gene superfamily. Science 1990; 247: 1219-1222 [PMID: 1690453 DOI: 10.1126/science.1690453]
58. Strilić B, Kucera T, Eglinger J, Hughes MR, McNagny KM, Tsukita S, Dejana E, Ferrara N, Lammert E. The molecular basis of vascular lumen formation in the developing mouse aorta. Dev Cell 2009; 17: 505-515 [PMID: 19853564 DOI: 10.1016/j.devcel.2009.08.011]
59. Pallari HM, Lindqvist J, Torvaldson E, Ferraris SE, He T, Sahlgren C, Eriksson JE. Nestin as a regulator of Cdk5 in differentiating myoblasts. Mol Biol Cell 2011; 22: 1539-1549 [PMID: 21346193 DOI: 10.1091/mbc.E10-07-0568]
60. Takebayashi Y, Natugoe S, Baba M, Fukumoto T, Takao S, Akiba S, Akiyama S, Aikou T. Angiogenesis in esophageal squamous cell carcinoma. Oncol Rep 1998; 5: 401-404 [PMID: 9468567]
61. Saad RS, Lindner JL, Liu Y, Silverman JF. Lymphatic vessel density as prognostic marker in esophageal adenocarcinoma. Am J Clin Pathol 2009; 131: 92-98 [PMID: 19095571 DOI: 10.1309/AJCPKWUQSIPVG90H]
62. Saad RS, El-Gohary Y, Memari E, Liu YL, Silverman JF. Endoglin (CD105) and vascular endothelial growth factor as prognostic markers in esophageal adenocarcinoma. Hum Pathol 2005; 36: 955-961 [PMID: 16153457 DOI: 10.1016/j.humpath.2005.06.019]
63. Elpek GO, Gelen T, Aksoy NH, Erdoǧan A, Dertsiz L, Demircan A, Keleş N. The prognostic relevance of angiogenesis and mast cells in squamous cell carcinoma of the oesophagus. J Clin Pathol 2001; 54: 940-944 [PMID: 11729214 DOI: 10.1136/jcp.54.12.940]
64. Igarashi M, Dhar DK, Kubota H, Yamamoto A, El-Assal O, Nagasue N. The prognostic significance of microvessel density and thymidine phosphorylase expression in squamous cell carcinoma of the esophagus. Cancer 1998; 82: 1225-1232 [PMID: 9529012]
65. Du JR, Jiang Y, Zhang YM, Fu H. Vascular endothelial growth factor and microvascular density in esophageal and gastric carcinomas. World J Gastroenterol 2003; 9: 1604-1606 [PMID: 12854174]
66. Coşkun U, Akyürek N, Dursun A, Yamaç D. Peritumoral lymphatic microvessel density associated with tumor progression and poor prognosis in gastric carcinoma. J Surg Res 2010; 164: 110-115 [PMID: 19628230]
67. Wei YZ, Li CF, Xue YW. [Expression of transcription factor SP1, vascular endothelial growth factor and CD34 in serosainfiltrating gastric cancer and their relationship with biological behavior and prognosis]. Zhonghua Weichang Waike Zazhi 2009; 12: 145-149 [PMID: 19296249]
68. Des Guetz G, Uzzan B, Nicolas P, Cucherat M, Morere JF, Benamouzig R, Breau JL, Perret GY. Microvessel density and VEGF expression are prognostic factors in colorectal cancer. Meta-analysis of the literature. Br J Cancer 2006; 94: 1823-1832 [PMID: 16773076 DOI: 10.1038/sj.bjc.6603176]
69. Tomisaki S, Ohno S, Ichiyoshi Y, Kuwano H, Maehara Y, Sugimachi K. Microvessel quantification and its possible relation with liver metastasis in colorectal cancer. Cancer 1996; 77: 1722-1728 [PMID: 8608569]
70. Poon RT, Ng IO, Lau C, Yu WC, Yang ZF, Fan ST, Wong J. Tumor microvessel density as a predictor of recurrence after resection of hepatocellular carcinoma: a prospective study. J Clin Oncol 2002; 20: 1775-1785 [PMID: 11919234 DOI: 10.1200/JCO.2002.07.089]
71. Wang SN, Yeh YT, Yang SF, Chai CY, Lee KT. Potential role of leptin expression in hepatocellular carcinoma. J Clin Pathol 2006; 59: 930-934 [PMID: 16565221 DOI: 10.1136/jcp.2005.035477]
72. Yang XR, Xu Y, Yu B, Zhou J, Qiu SJ, Shi GM, Zhang BH, Wu WZ, Shi YH, Wu B, Yang GH, Ji Y, Fan J. High expression levels of putative hepatic stem/progenitor cell biomarkers related to tumour angiogenesis and poor prognosis of hepatocellular carcinoma. Gut 2010; 59: 953-962 [PMID: 20442200 DOI: 10.1136/gut.2008.176271]
73. Yang P, Yuan W, He J, Wang J, Yu L, Jin X, Hu Y, Liao M, Chen Z, Zhang Y. Overexpression of EphA2, MMP-9, and MVD-CD34 in hepatocellular carcinoma: Implications for tumor progression and prognosis. Hepatol Res 2009; 39: 1169-1177 [PMID: 19788698 DOI: 10.1111/j.1872-034X.2009.00563.x]
74. Tseng PL, Tai MH, Huang CC, Wang CC, Lin JW, Hung CH, Chen CH, Wang JH, Lu SN, Lee CM, Changchien CS, Hu TH. Overexpression of VEGF is associated with positive p53 immunostaining in hepatocellular carcinoma (HCC) and adverse outcome of HCC patients. J Surg Oncol 2008; 98: 349-357 [PMID: 18646041 DOI: 10.1002/jso.21109]
75. Sun HC, Tang ZY, Li XM, Zhou YN, Sun BR, Ma ZC. Microvessel density of hepatocellular carcinoma: its relationship with prognosis. J Cancer Res Clin Oncol 1999; 125: 419-426 [PMID: 10394963 DOI: 10.1007/s004320050296]
76. van der Zee JA, van Eijck CH, Hop WC, van Dekken H, Dicheva BM, Seynhaeve AL, Koning GA, Eggermont AM, ten Hagen TL. Angiogenesis: a prognostic determinant in pancreatic cancer? Eur J Cancer 2011; 47: 2576-2584 [PMID: 21958461]
77. Niedergethmann M, Hildenbrand R, Wostbrock B, Hartel M, Sturm JW, Richter A, Post S. High expression of vascular endothelial growth factor predicts early recurrence and poor prognosis after curative resection for ductal adenocarcinoma of the pancreas. Pancreas 2002; 25: 122-129 [PMID: 12142733 DOI: 10.1097/00006676-200208000-00002]
78. Niedergethmann M, Hildenbrand R, Wolf G, Verbeke CS, Richter A, Post S. Angiogenesis and cathepsin expression are prognostic factors in pancreatic adenocarcinoma after curative resection. Int J Pancreatol 2000; 28: 31-39 [PMID: 11185708]
79. Offersen BV, Borre M, Overgaard J. Immunohistochemical determination of tumor angiogenesis measured by the maximal microvessel density in human prostate cancer. APMIS 1998; 106: 463-469 [PMID: 9637268 DOI: 10.1111/j.1699-0463.1998.tb01372.x]
80. Borre M, Offersen BV, Nerstrøm B, Overgaard J. Microvessel density predicts survival in prostate cancer patients subjected to watchful waiting. Br J Cancer 1998; 78: 940-944 [PMID: 9764587 DOI: 10.1038/bjc.1998.605]
81. Borre M, Offersen IB, Nerstrøm B, Overgaard J. [Angiogenesis: prognostic marker in prostatic cancer]. Ugeskr Laeger 1999; 161: 3832-3836 [PMID: 10412301]
82. Rubin MA, Buyyounouski M, Bagiella E, Sharir S, Neugut A, Benson M, de la Taille A, Katz AE, Olsson CA, Ennis RD. Microvessel density in prostate cancer: lack of correlation with tumor grade, pathologic stage, and clinical outcome. Urology 1999; 53: 542-547 [PMID: 10096381 DOI: 10.1016/S0090-4295(98)00561-5]
83. de la Taille A, Katz AE, Bagiella E, Buttyan R, Sharir S, Olsson CA, Burchardt T, Ennis RD, Rubin MA. Microvessel density as a predictor of PSA recurrence after radical prostatectomy. A comparison of CD34 and CD31. Am J Clin Pathol 2000; 113: 555-562 [PMID: 10761458 DOI: 10.1309/02W2-KE50-PKEF-G2G4]
84. Mahzouni P, Mohammadizadeh F, Mougouei K, Moghaddam NA, Chehrei A, Mesbah A. Determining the relationship between "microvessel density" and different grades of astrocytoma based on immunohistochemistry for "factor VIIIrelated antigen" (von Willebrand factor) expression in tumor microvessels. Indian J Pathol Microbiol 2010; 53: 605-610 [PMID: 21045378]
85. Yao Y, Kubota T, Takeuchi H, Sato K. Prognostic significance of microvessel density determined by an anti-CD105/endoglin monoclonal antibody in astrocytic tumors: comparison with an anti-CD31 monoclonal antibody. Neuropathology 2005; 25: 201-206 [PMID: 16193836 DOI: 10.1111/j.1440-1789.2005.00632.x]
86. Preusser M, Heinzl H, Gelpi E, Schonegger K, Haberler C, Birner P, Marosi C, Hegi M, Gorlia T, Hainfellner JA. Histopathologic assessment of hot-spot microvessel density and vascular patterns in glioblastoma: Poor observer agreement limits clinical utility as prognostic factors: a translational research project of the European Organization for Research and Treatment of Cancer Brain Tumor Group. Cancer 2006; 107: 162-170 [PMID: 16721804]